This inventor holds 1 USPTO granted patent. Top assignee: Merck Patent Gmbh. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Claudia Cases: Innovator in Cancer Treatment
Introduction
Claudia Cases is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of cancer treatment through her innovative research and development of pharmaceutical compounds. Her work focuses on creating effective inhibitors for specific kinases involved in tumor growth.
Latest Patents
Claudia holds a patent for "4-Amino-5-oxo-8-phenyl-5H-pyrido(2,3-D) pyrimidine derivatives as tyrosine kinase and raf kinase inhibitors for the treatment of tumours." This patent describes compounds that act as inhibitors of tyrosine kinases, particularly TIE-2, and Raf kinases. These compounds can be employed in the treatment of various tumors, showcasing her commitment to advancing cancer therapies.
Career Highlights
Claudia is currently associated with Merck Patent GmbH, where she continues to push the boundaries of pharmaceutical innovation. Her work has been instrumental in developing new therapeutic strategies that target critical pathways in cancer progression.
Collaborations
Throughout her career, Claudia has collaborated with notable professionals in her field, including Jaume Adan and Wilfried Rautenberg. These partnerships have enhanced her research and contributed to the successful development of her patented compounds.
Conclusion
Claudia Cases exemplifies the spirit of innovation in the pharmaceutical industry, particularly in cancer treatment. Her contributions through her patent and collaborations highlight her dedication to improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile